MA
Mark Arnold Hagler bought $86K of NBP stock
Mark Arnold Hagler, Chief Commercial Officer of NovaBridge Biosciences (NBP), bought 230,000 shares of NBP stock worth $86K, per an SEC Form 4 filed Nov 19, 2026.
It was an open-market purchase.
The trade happened on Nov 17, 2026, 2 days before it was made public.
NBP has moved +0.0% since the trade date, from $0.82 to $0.82 (Nov 17, 2026 close).
- Traded
- Nov 17, 2026
- Disclosed
- Nov 19, 2026
- Filing delay
- 2 days
- Price since
- +0.0%
- Role
- Chief Commercial Officer
- Source
- SEC Form 4